Jürgen Floege, MD / Richard Lafayette, MD, FACP - Strategies to Success in IgAN Management: Harmonizing the Latest Evidence and Guidance to Maximize the Potential of Foundation Treatment Strategies

What this episode covers

For the complete activity, including supporting material, please visit https://www.peervoice.com/NCD860. Presented by Jürgen Floege, MD and Richard Lafayette, MD, FACP Learning Objectives: Recognize the role of the gut mucosal immune system in the pathogenesis of IgA nephropathy (IgAN); Summarize the evidence related to current guideline-recommended treatment approaches to address the IgAN-specific drivers of nephron loss; Formulate practical strategies to identify when to escalate care to optimize outcomes in patients with IgAN; Integrate the KDIGO 2025 recommendations into clinical practice to establish foundational treatment strategies that optimize outcomes for patients with IgAN.

Distinct summary based on available episode metadata or transcript content.